c jun n terminal kinase jnk (Cell Signaling Technology Inc)
86
Structured Review
Cell Signaling Technology Inc
c jun n terminal kinase jnk
C Jun N Terminal Kinase Jnk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+jun+n+terminal+kinase+jnk/pmc13062727-83-23-27
Average 86 stars, based on 1 article reviews
C Jun N Terminal Kinase Jnk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+jun+n+terminal+kinase+jnk/pmc13062727-83-23-27
Average 86 stars, based on 1 article reviews
c jun n terminal kinase jnk - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Incubation:Article Title: HDAC inhibitors restore osteoimmune balance and bone regeneration via selective MAPK modulation in inflammatory bone disease Article Snippet: .. Then the membranes were incubated overnight at 4°C with primary antibodies against RUNX2 (Cell Signaling Technology, Danvers, MA, USA), ALP (Bioss Antibodies, Woburn, MA, USA), bone sialoprotein (BSP) (Cell Signaling Technology), extracellular signal-regulated kinase (ERK) (Cell Signaling Technology), phospho-ERK (Cell Signaling Technology), Cell-Signaling:Article Title: HDAC inhibitors restore osteoimmune balance and bone regeneration via selective MAPK modulation in inflammatory bone disease Article Snippet: .. Then the membranes were incubated overnight at 4°C with primary antibodies against RUNX2 (Cell Signaling Technology, Danvers, MA, USA), ALP (Bioss Antibodies, Woburn, MA, USA), bone sialoprotein (BSP) (Cell Signaling Technology), extracellular signal-regulated kinase (ERK) (Cell Signaling Technology), phospho-ERK (Cell Signaling Technology), ALP Assay:Article Title: HDAC inhibitors restore osteoimmune balance and bone regeneration via selective MAPK modulation in inflammatory bone disease Article Snippet: .. Then the membranes were incubated overnight at 4°C with primary antibodies against RUNX2 (Cell Signaling Technology, Danvers, MA, USA), ALP (Bioss Antibodies, Woburn, MA, USA), bone sialoprotein (BSP) (Cell Signaling Technology), extracellular signal-regulated kinase (ERK) (Cell Signaling Technology), phospho-ERK (Cell Signaling Technology), Western Blot:Article Title: Goreisan attenuates cardiac hypertrophy and diastolic dysfunction in heart failure with preserved ejection fraction induced by HFD/L-NAME via regulation of ICAT-β-catenin/ERK axis Article Snippet: .. For immunoblot analyses, we used antibodies against phosphorylation of extracellular signal-regulated kinase (p-ERK) (1:5000, CST #9101), ERK (1:5000, CST #9102), Phospho-proteomics:Article Title: Goreisan attenuates cardiac hypertrophy and diastolic dysfunction in heart failure with preserved ejection fraction induced by HFD/L-NAME via regulation of ICAT-β-catenin/ERK axis Article Snippet: .. For immunoblot analyses, we used antibodies against phosphorylation of extracellular signal-regulated kinase (p-ERK) (1:5000, CST #9101), ERK (1:5000, CST #9102), other:Article Title: Tonsil‑derived mesenchymal stem cell‑derived extracellular vesicles suppress MAPK‑NF‑κB signaling and restore osteogenic differentiation in LPS‑stimulated periodontal ligament fibroblasts. Article Snippet: Primary antibodies against β‐actin, p65, c‐Jun, and c‐Fos (Santa Cruz Biotechnology, Inc.), as well as phosphorylated or total extracellular signal‐regulated kinase (ERK) and |